• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line.

作者信息

Allen L E, Maher P A

机构信息

Department of Molecular and Cellular Growth Biology, Whittier Institute for Diabetes and Endocrinology, La Jolla, California 92037.

出版信息

J Cell Physiol. 1993 May;155(2):368-75. doi: 10.1002/jcp.1041550218.

DOI:10.1002/jcp.1041550218
PMID:8387074
Abstract

Basic fibroblast growth factor (bFGF) is a multifunctional growth factor that can stimulate cell proliferation, production of proteases, and angiogenesis. Loss of mechanisms that regulate bFGF activity could result in tumor development. To test this idea, cells derived from an invasive bladder carcinoma (EJ) were compared with cells derived from a noninvasive bladder carcinoma (RT4) for the expression of bFGF and high and low affinity FGF receptors. bFGF was produced by the invasive EJ cells but not by the noninvasive RT4 cells, suggesting that bFGF could act in an autocrine fashion in the EJ cells to promote their invasion and growth in the surrounding tissue. The two cells lines also showed differences in FGF receptor expression. The EJ cells expressed both high and low affinity FGF receptors as determined by Scatchard analysis, whereas the RT4 cells expressed only high affinity receptors. The high affinity receptors on the RT4 cells were not recognized by an antibody to known FGF receptors. Furthermore, in contrast to the EJ cells, bFGF did not induce protein tyrosine phosphorylation in the RT4 cells. Thus these data suggest that the invasive potential of bladder carcinoma cells may be regulated by the expression of both bFGF and its receptors.

摘要

相似文献

1
Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line.
J Cell Physiol. 1993 May;155(2):368-75. doi: 10.1002/jcp.1041550218.
2
Overexpression of basic fibroblast growth factor in MCF-7 human breast cancer cells: lack of correlation between inhibition of cell growth and MAP kinase activation.碱性成纤维细胞生长因子在MCF-7人乳腺癌细胞中的过表达:细胞生长抑制与丝裂原活化蛋白激酶激活之间缺乏相关性。
J Cell Physiol. 1998 Dec;177(3):411-25. doi: 10.1002/(SICI)1097-4652(199812)177:3<411::AID-JCP5>3.0.CO;2-Y.
3
Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines.
J Cell Physiol. 1992 Feb;150(2):320-6. doi: 10.1002/jcp.1041500215.
4
Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancer.碱性成纤维细胞生长因子诱导膀胱癌血管生成的两种机制。
Cancer Res. 1997 Jan 1;57(1):136-40.
5
Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.碱性成纤维细胞生长因子:一种人类胶质瘤细胞生长的潜在自分泌调节因子。
J Neurosci Res. 1990 Dec;27(4):689-96. doi: 10.1002/jnr.490270429.
6
Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.毛细血管内皮细胞在碱性成纤维细胞生长因子诱导的旁分泌信号传导方面的异质性。
Endothelium. 2006 May-Jun;13(3):191-203. doi: 10.1080/10623320600760415.
7
[Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].[浅表性移行细胞膀胱癌中血管内皮生长因子(VEGF)和碱性成纤维细胞生长因子(bFGF)的表达]
Ai Zheng. 2003 Mar;22(3):307-9.
8
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.卡波西肉瘤(KS)中存在的血管内皮生长因子和碱性成纤维细胞生长因子由炎性细胞因子诱导产生,并协同作用以促进血管通透性和卡波西肉瘤病变发展。
Am J Pathol. 1998 Jun;152(6):1433-43.
9
Basic fibroblast growth factor enhanced LAK cell cytotoxicities against human bladder neoplasm cells.碱性成纤维细胞生长因子增强了LAK细胞对人膀胱肿瘤细胞的细胞毒性。
Zhongguo Yao Li Xue Bao. 1999 Mar;20(3):276-8.
10
FGF-2 and FGF-1 expressed in rat bladder carcinoma cells have similar angiogenic potential but different tumorigenic properties in vivo.在大鼠膀胱癌细胞中表达的FGF - 2和FGF - 1在体内具有相似的血管生成潜力,但具有不同的致瘤特性。
Oncogene. 1997 Feb 13;14(6):671-6. doi: 10.1038/sj.onc.1200883.

引用本文的文献

1
Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity.成纤维细胞生长因子受体 3 的基因干扰通过减轻 RAS/MAPK 信号活性阻碍上尿路尿路上皮癌细胞的侵袭。
Int J Mol Sci. 2023 Jan 16;24(2):1776. doi: 10.3390/ijms24021776.
2
AKT Isoforms in the Immune Response in Cancer.AKT 异构体在癌症免疫反应中的作用。
Curr Top Microbiol Immunol. 2022;436:349-366. doi: 10.1007/978-3-031-06566-8_15.
3
The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.
癌症免疫图谱作为膀胱癌个体化免疫治疗的框架。
Eur Urol. 2019 Mar;75(3):435-444. doi: 10.1016/j.eururo.2018.09.022. Epub 2018 Sep 28.
4
Different stages in drug development for muscle-invasive bladder cancer.肌层浸润性膀胱癌药物研发的不同阶段。
Transl Androl Urol. 2017 Dec;6(6):1060-1066. doi: 10.21037/tau.2017.11.22.
5
Analyses of publicly available genomics resources define FGF-2-expressing bladder carcinomas as EMT-prone, proliferative tumors with low mutation rates and high expression of CTLA-4, PD-1 and PD-L1.分析公开可用的基因组学资源,将表达 FGF-2 的膀胱癌定义为 EMT 倾向、增殖性肿瘤,其突变率低,CTLA-4、PD-1 和 PD-L1 表达水平高。
Signal Transduct Target Ther. 2017;2:16045-. doi: 10.1038/sigtrans.2016.45. Epub 2017 Mar 17.
6
Muscle-invasive urothelial bladder cancer: an update on systemic therapy.肌层浸润性膀胱尿路上皮癌:全身治疗的最新进展
Ther Adv Urol. 2015 Dec;7(6):312-30. doi: 10.1177/1756287215607418.
7
Targeted therapy in advanced bladder cancer: what have we learned?晚期膀胱癌的靶向治疗:我们学到了什么?
Urol Clin North Am. 2015 May;42(2):253-62, ix. doi: 10.1016/j.ucl.2015.01.006. Epub 2015 Mar 12.
8
Molecular targets on the horizon for kidney and urothelial cancer.展望用于肾和尿路上皮癌的分子靶标。
Nat Rev Clin Oncol. 2013 Oct;10(10):557-70. doi: 10.1038/nrclinonc.2013.155. Epub 2013 Aug 27.
9
Novel agents for advanced bladder cancer.晚期膀胱癌的新型药物。
Ther Adv Med Oncol. 2009 Jul;1(1):37-50. doi: 10.1177/1758834009337776.
10
Targeting angiogenesis in bladder cancer.靶向膀胱癌中的血管生成
Curr Oncol Rep. 2009 May;11(3):244-9. doi: 10.1007/s11912-009-0034-2.